Gevo (GEVO)

• Market cap: $307M
• 1 day: 4.07%
• 5 days: 10.34%
• 1 month: 3.23%
• 3 months: 7.56%
• 6 months: -16.88%
• Year to date: -44.83%
• 1 year: 110.77%
• 5 years: 7.56%
• 10 years: -99.91%
• Sector: Materials
• Industry: Specialty Chemicals

About: Gevo Inc is a renewable chemicals and biofuels company engaged in the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. The operating segments are the Gevo segment, GevoFuels segment, and the GevoRNG segment. By its segments, it is involved in research and development activities related to the future production of SAF, commercial opportunities for other renewable hydrocarbon products and isobutanol, including the development of its biocatalysts, and the produces-pipeline quality methane gas captured from dairy cow manure. The company derives maximum revenue from the GevoRNG segment.

Employees: 122

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

181% more call options, than puts

Call options by funds: $1.87M | Put options by funds: $666K

114% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 14

23% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 30

14% more funds holding

Funds holding: 104 [Q4 2024] → 119 (+15) [Q1 2025]

2.29% more ownership

Funds ownership: 21.54% [Q4 2024] → 23.83% (+2.29%) [Q1 2025]

39% less capital invested

Capital invested by funds: $108M [Q4 2024] → $66.2M (-$41.7M) [Q1 2025]

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $1.15 10% downside
• Avg. target: $7.58 492% upside
• High target: $14 994% upside

2 analyst ratings

• positive: 1 50%
• neutral: 1 50%
• negative: 0 0%

HC Wainwright & Co. Amit Dayal	994% upside $14	Buy Reiterated	30 May 2025
UBS Manav Gupta	10% downside $1.15	Neutral Maintained	2 Apr 2025